E2F4通过转录激活MUC1表达来促进前列腺癌的恶性行为
Long Cheng1,2, Haichao Yang3, Shuoguo Tan4
1Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou City, China.
Asia-Pacific journal of clinical oncology
|March 20, 2025
概括
提高E2F4驱动前列腺癌 (PC) 恶性通过增加MUC1表达. 向E2F4或MUC1可以抑制PC生长和转移,提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 前列腺癌 (PC) 由于其恶性特征而构成重大威胁.
- 在PC中,素1 (MUC1) 表达显著升高,但潜在的机制尚不清楚.
研究的目的:
- 研究E2F4在调节前列腺癌中MUC1表达中的作用.
- 探索E2F4-MUC1轴对PC细胞恶性瘤的影响,并确定潜在的治疗点.
主要方法:
- 定量实时PCR (RT-qPCR) 用于评估PC组织和细胞中的MUC1和E2F4水平.
- 功能性检测包括克隆形成,划痕,穿孔和流动细胞计,以评估恶性表型.
- 生物信息分析 (JASPAR), luciferase 记者测定和染色体免疫沉 (ChIP) 来证实E2F4与MUC1促进体的相互作用.
主要成果:
- 在PC样本和细胞中,MUC1和E2F4都被发现显著上调.
- 沉默MUC1抑制了PC细胞生长和转移,同时促进了细胞亡.
- E2F4被确定为MUC1的转录激活剂,增强其表达并促进恶性表型. 由于MUC1过度表达,E2F4的淘汰效应被逆转.
结论:
- 通过调节MUC1表达,E2F4促进前列腺癌的进展.
- 针对E2F4-MUC1通路提供了一种有前途的治疗策略,可以抑制PC生长,转移,并增强亡.
相关概念视频
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


